SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 8-K
Document Type: EX-10.1
Date Filed: 2026-03-25
Accession Number: 0001213900-26-034072
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390026034072/ea028322301ex10-1.htm

Chunk 64 of 68
Word Count: 1434
Character Count: 8807

Document Content:

on which final judgment is given. The obligation of each Loan Party in respect of any such sum due from it to the Secured Parties hereunder shall, notwithstanding any judgment in such Other Currency, be discharged only to the extent that, on the Business Day immediately following the date on which the Administrative Agent receives any sum adjudged to be so due in the Other Currency, the Administrative Agent may, in accordance with normal banking procedures, purchase Dollars with the Other Currency. If the Dollars so purchased are less than the sum originally due to the Secured Parties in Dollars, each Loan Party agrees, as a separate obligation and notwithstanding any such judgment, to indemnify the Secured Parties against such loss, and if the Dollars so purchased exceed the sum originally due to the Secured Parties in Dollars, the Secured Parties agrees to remit to the Loan Parties such excess.

Section
11.24. Waiver of Immunity. To the extent that any Loan Party has or hereafter may acquire (or may be attributed, whether or
not claimed) any immunity (sovereign or otherwise) from any legal action, suit or proceeding, from jurisdiction of any court or from
set-off or any legal process (whether service of process or notice, attachment prior to judgment, attachment in aid of execution of judgment,
execution of judgment or otherwise) with respect to itself or any of its property, such Loan Party hereby irrevocably waives and agrees
not to plead or claim, to the fullest extent permitted by law, such immunity in respect of (a) its obligations under the Loan Documents,
(b) any legal proceedings to enforce such obligations and (c) any legal proceedings to enforce any judgment rendered in any proceedings
to enforce such obligations. Each Loan Party hereby agrees that the waivers set forth in this Section 11.24 shall be to the fullest extent
permitted under the Foreign Sovereign Immunities Act and are intended to be irrevocable for purposes of the Foreign Sovereign Immunities
Act.

Section
11.25. English Language. This Agreement and each other Loan Document have been negotiated and executed in English. All certificates,
reports, notices and other documents and communications given or delivered by any party hereto pursuant to this Agreement or any other
Loan Document shall be in English or, if not in English, accompanied by a certified English translation thereof. The English version
of any such document shall control the meaning of the matters set forth herein.

[REMAINDER
OF THIS PAGE INTENTIONALLY LEFT BLANK]

[SIGNATURE
PAGES OMITTED]

Exhibit

Lender
Warrant

(attached)

THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, APPLICABLE
STATE SECURITIES LAWS, OR APPLICABLE LAWS OF ANY FOREIGN JURISDICTION. THIS WARRANT AND SUCH UNDERLYING SECURITIES HAVE BEEN ACQUIRED
FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE OFFERED, SOLD, PLEDGED, HYPOTHECATED, RENOUNCED OR OTHERWISE
TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS AND
IN THE ABSENCE OF COMPLIANCE WITH APPLICABLE LAWS OF ANY FOREIGN JURISDICTION, OR THE AVAILABILITY OF AN EXEMPTION FROM THE REGISTRATION
PROVISIONS OF THE SECURITIES ACT OF 1933, AS AMENDED, AND APPLICABLE STATE SECURITIES LAWS.

SYNERGY
CHC CORP.

COMMON
STOCK PURCHASE WARRANT

This
Common Stock Purchase Warrant (the “Warrant”) is issued as of the 24th day of March 2026, by Synergy CHC Corp., a
Nevada corporation (the “Company”), to ACME CREDIT PARTNERS FUND I, LP (the “Holder”). The Holder
is a lender under that certain Term Loan Credit Agreement, dated as of May 30, 2025, as amended (the “Credit Agreement”).
All capitalized terms used herein which are not defined herein shall have the meanings ascribed to them in the Credit Agreement.

Issuance of Warrant; Term; Price.

1.1. Issuance.
Concurrently herewith, the Company is executing a Second Amendment to the Credit Agreement and this Warrant is being issued to enhance
the security of the collateral for the due and punctual payment and performance by the Loan Parties of all of the Obligations under the
Credit Agreement and the other Loan Documents (collectively, the “Secured Obligations”). In consideration of Holder’s
agreement to purchase the Shares, the Company hereby grants to Holder the right to purchase Three Million (3,000,000) shares of the Company’s
common stock (the “Common Stock”). The shares of Common Stock or other securities for which this Warrant may be exercisable
from time to time shall be referred to herein as the “Warrant Stock.” The shares of Warrant Stock issuable upon exercise
of this Warrant are hereinafter referred to as the “Shares.” The Company shall register ownership of this Warrant,
upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record
Holder (which shall include the initial Holder or, as the case may be, any assignee to which this Warrant is assigned hereunder) from
time to time. With a view to making available to the Holder the benefits of Rule 144 and any other rule or regulation of the Securities
and Exchange Commission (the “Commission”) that may at any time permit a holder to sell securities of the Company
to the public without registration or pursuant to a registration statement, the Company shall: (i) use best efforts to make and keep
adequate public information available, as required by clause (c) of Rule 144, (ii) use best efforts to file with the Commission in a
timely manner all reports and other documents required of the Company under the Securities Act and the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), and (iii) furnish, or otherwise make available to the Holder so long as the Holder
owns Warrant Stock, promptly upon request, a written statement by the Company as to its compliance with the reporting requirements of
Rule 144 and the Exchange Act, a copy of the most recent annual or quarterly report of the Company, and such other reports and documents
so filed or furnished by the Company as such Holder may reasonably request in connection with the sale of Common Stock without registration.
The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof
or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

1.2 Term;
Exercise. This Warrant shall have a term of ten years and will become exercisable upon a Qualified Event of Default. For purposes
of this Warrant, a “Qualified Event of Default” shall mean the occurrence of any Event of Default under Section 8.1(a)
of the Credit Agreement. Upon the occurrence of the indefeasible payment, performance and satisfaction in full of all Secured Obligations,
this Warrant shall terminate.

1.3 Exercise
Price. Subject to adjustment as hereinafter provided, the exercise price (the “Warrant Price”) per share for which
all or any of the Shares may be purchased pursuant to the terms of this Warrant shall be equal to $0.00001.

Adjustment of Warrant Price, Number and Kind of Shares. The Warrant Price and the number and kind of Shares issuable upon the
exercise of this Warrant shall be subject to adjustment from time to time as follows.

2.1. Dividends
in Stock Adjustment. In case at any time or from time to time on or after the date on which this Warrant is exercisable for Warrant
Stock and while this Warrant is outstanding and unexpired, the holders of the Warrant Stock of the Company (or any shares of stock or
other securities at the time receivable upon the exercise of this Warrant) shall have received, or, on or after the record date fixed
for the determination of eligible stockholders, shall have become entitled to receive, without payment therefor, other or additional
securities or other property (other than cash) of the Company by way of dividend or distribution, then and in each case, the holder of
this Warrant shall, upon the exercise hereof, be entitled to receive, in addition to the number of shares of Warrant Stock receivable
thereupon, and without payment of any additional consideration therefor, the amount of such other or additional securities or other property
(other than cash) of the Company which such holder would have been entitled to receive if it had exercised this Warrant on the date hereof
and thereafter, during the period from the date hereof to and including the date of such exercise, retained such shares and/or all other
additional securities or other property receivable by it as aforesaid during such period, giving effect to all adjustments called for
during such period by this Section 2.